• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED - Charts / Financials

1.47% ! 6.7¢
Market Cap $108.8M  !
Healthcare Biotechnology
Add to My Watchlist

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 7.8¢   Day High 8.3¢   Day Low 6.5¢
Daily Volume 23302625
Bids   Sellers
Number Price Volume   Number Price Volume
1 6.6¢ 3255   1 6.8¢ 50000

Directors & Senior Management

Mr. Gary Jonathan Phillips Chief Executive Officer, Managing Director, Executive Director
Mr. David Morris Mcgarvey Chief Financial Officer
Dr. Jana Baskar Chief Medical Officer
Mr. Wolfgang G. Jarolimek Head - Drug Discovery
Ms. Kristen Morgan Alliance Management - Head of Medical and Regulatory Affairs
Mr. Cameron Billingsley Company Secretary
Dr. Kathleen Mary Metters Non-Executive Independent Chairman of the Board
Dr. Simon P. Green Non-Executive Director
Mr. Waradana Malitha Hashan De Silva Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.7¢ 		Change
-0.001(1.47%) 		Mkt cap ! $108.8M
Open High Low Value Volume
7.8¢ 8.3¢ 6.5¢ $1.693M 23.30M

Buyers (Bids)

No. Vol. Price($)
1 3255 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 50000 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?

Top Stories

Gold, Brent Crude spike as Israel strikes Iran in worst-case scenario

Israel has come good on its threats to attack Iran on Friday morning, with strikes in Tehran reported by AP and Al Jazeera. Secondary but unconfirmed attacks have also been reported across X (formerly Twitter) today, too.Listen to the HotCopper podcast for in-depth discussions and insights on all...
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing) Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing By and large, I don't think I'd be without peers when I said the biggest thing that happened this week was on energy markets.
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.